Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy (DMD)

This research aims to improve the quality of life, occupational performance, occupational satisfaction and emotional health of young people with Duchenne muscular dystrophy compared to the classical occupational therapy program. The findings are planned to shed light on the development of new and effective strategies in the rehabilitation of adolescents with Duchenne muscular dystrophy.

Study Overview

• Status: Recruiting
• Conditions: Duchenne Muscular Dystrophy; Occupational Therapy; Gamification
• Intervention / Treatment: Other: Gamified occupational therapy programme; Other: Classic occupational therapy programme

• Study Type: Interventional
• Enrollment (Estimated): 20
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Başak Çağla Arslan, Master Degree; Phone Number: 4448548; Email: ptbasakc@gmail.com

Study Locations

• Turkey (Türkiye)
  • Ankara, Turkey (Türkiye), 06510
    • Recruiting
    • Lokman Hekim University
    • Contact: Başak Çağla Arslan, Master's Degree

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Being diagnosed with Duchenne muscular dystrophy
• To be literate in Turkish
• To have scored 27 points or more on the Modified Mini Mental Test
• Having a computer, tablet and internet connection
• Volunteering to participate in the study by their parents and reading and signing the informed consent form

Exclusion Criteria:

• Having a neurological disease other than Duchenne muscular dystrophy and/or another diagnosed neurological disease accompanying Duchenne muscular dystrophy
• Having a cooperation problem that prevents completing the assessments for any reason
• Difficulty understanding and speaking the Turkish language

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Experimental group; Gamified occupational therapy programme group	Other: Gamified occupational therapy programme; Gamified occupational therapy program for the experimental group and classical occupational therapy program for the control group, which will be applied to both groups for eight weeks
Other: Control group; Classic occupational therapy group	Other: Classic occupational therapy programme; Gamified occupational therapy program for the experimental group and classical occupational therapy program for the control group, which will be applied to both groups for eight weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Demographic information form		At the start of the evaluations
Modified Mini Mental State Test		before and after the eight-week intervention programs
The Pediatric Quality of Life Inventory 3.0 Neuromuscular Module		before and after the eight-week intervention programs
Canadian Occupational Performance Measure		before and after the eight-week intervention programs
Vignos lower extremity functional scale	This scale was developed to assess the level of ambulation in neuromuscular diseases and consists of 10 stages. In this scale, the ambulation level of the person decreases from the first stage to the tenth stage.	before and after the eight-week intervention programs
Brooke upper extremity functional classification scale	This scale was developed to assess the functional levels of the upper extremity in neuromuscular diseases and consists of 6 stages. In this scale, progression from the first stage to the sixth stage indicates a decrease in the functionality of the upper extremity.	before and after the eight-week intervention programs
The Pediatric Quality of Life Inventory Multidimensional Fatigue Scale	This scale consists of 18 items and 3 subsections: general fatigue (6 items), fatigue during sleep/rest (6 items) and cognitive fatigue (6 items). Separate scores can be calculated for each subsection and the total score is obtained by summing the scores obtained from these sections. High scores indicate low fatigue.	before and after the eight-week intervention programs
The Numeric Rating Scale - Pain	This scale uses a 10-centimeter line. The left beginning of the line represents "no pain" (0 points) and the end of the line represents "excruciating pain" (10 points).	before and after the eight-week intervention programs
Children's Depression Inventory	Consisting of 27 items and using a 3-point Likert-type scale, this scale assesses the depression levels of children between the ages of 6-17. The total score of the scale, which measures the emotional state in the last 2 weeks, is 54 and the severity of depression increases as the total score increases. The cut-off value of the scale was determined as 19 points.	before and after the eight-week intervention programs

Collaborators and Investigators

• Sponsor: Başak Çağla Arslan
• Collaborators: Hacettepe University

Study record dates

Study Major Dates

• Study Start (Actual): May 1, 2025
• Primary Completion (Estimated): August 21, 2026
• Study Completion (Estimated): December 8, 2026

Study Registration Dates

• First Submitted: May 3, 2024
• First Submitted That Met QC Criteria: May 3, 2024
• First Posted (Actual): May 7, 2024

Study Record Updates

• Last Update Posted (Actual): January 27, 2026
• Last Update Submitted That Met QC Criteria: January 24, 2026
• Last Verified: January 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Musculoskeletal Diseases; Nervous System Diseases; Muscular Diseases; Neuromuscular Diseases; Genetic Diseases, Inborn; Genetic Diseases, X-Linked; Muscular Disorders, Atrophic; Muscular Dystrophies; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Muscular Dystrophy, Duchenne
• Other Study ID Numbers: LHU20241004; LHÜ (Other Identifier: LHÜ)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No